Allarity Therapeutics, Inc.

ALLR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$25-$12-$16-$27
Dep. & Amort.$0$0$0$0
Deferred Tax-$0$0-$2$0
Stock-Based Comp.$0-$0$2$6
Change in WC$0$3-$0$6
Other Non-Cash$7-$4-$1-$0
Operating Cash Flow-$17-$13-$17-$15
Investing Activities
PP&E Inv.-$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$1$1
Investing Cash Flow-$0$0$1$1
Financing Activities
Debt Repay.$0-$3$1$1
Stock Issued$40$17$0$32
Stock Repurch.-$4$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$3-$2$1
Financing Cash Flow$37$11-$1$34
Forex Effect$0-$0-$0-$1
Net Chg. in Cash$19-$2-$18$19
Supplemental Information
Beg. Cash$0$2$20$0
End Cash$20$0$2$20
Free Cash Flow-$18-$13-$17-$15
Allarity Therapeutics, Inc. (ALLR) Financial Statements & Key Stats | AlphaPilot